UNSPSC 85611710: Supplement cystic duct with autologous tissue substitute, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement cystic duct with autologous tissue substitute, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0FU837Z

UNSPSC 85611710 Supplement cystic duct with autologous tissue substitute, percutaneous approach is a Commodity code that does not align with the state and local procurement activity recently tagged to it. The recent opportunities show no solicitations for surgical procedures or tissue substitutes. Instead, the source reflects misclassification: the City of Phoenix is seeking independent medical evaluation services for disability benefit determinations; the City of Long Beach is requesting surgical procedure carve-out benefit management for employee health plans; the Washington State Department of Transportation is soliciting occupational medical surveillance services; Harris County Juvenile Probation Department is seeking hospital and specialty medical providers for youth in custody; Collier County is requesting pharmacy benefit management administration; and Santa Clara County Health System is building a vendor pool for temporary health professional staffing across ancillary clinical categories. These represent health plan administration, medical surveillance, clinical staffing, and benefits management—none involve cystic duct supplementation or autologous tissue procedures.

The code shows little relevant recent activity. State and local procurement under this UNSPSC appears inactive or incorrectly tagged across the recent opportunities block. Pursuing this code as currently labeled is not supported by recent state and local solicitation data.